Candesic provided commercial due diligence to Ampersand Capital Partners By Candesic Ltd

Congratulations to the Ampersand Capital Partners team on their investment in Julius Clinical Research! Candesic provided commercial due diligence to Ampersand Capital Partners.

Julius Clinical is a leading academic clinical CRO providing clinical trial services and real-world evidence studies to biopharma sponsors. This strategic partnership will enhance Julius Clinical capabilities in pioneering clinical research and support the development of new therapeutics on a global scale.